封面
市場調查報告書
商品編碼
1291582

液體活體組織切片市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022年,全球液體活體組織切片市場規模達到18億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到43億美元,在2023-2028年期間表現出15.3%的成長率(CAGR)。

液體活體組織切片是一種非侵入性的替代手術活體組織切片的方法,使醫生能夠通過血液樣本獲得關於腫瘤的資訊並製定相應的治療計劃。它可以反映腫瘤基因表達譜的變化,並為個體化治療提供一個強大的基礎。它有助於早期診斷篩選、腫瘤異質性和耐藥性。除此之外,它還能檢測表皮生長因子受體(EGFR)的基因突變,這些突變發生在非小細胞肺癌(NSCLC)患者中。

液體活體組織切片市場趨勢:

由於久坐的生活方式和煙草消費的增加,全球癌症患者的數量激增。這一點,加上個人對癌症診斷中先進的微創(MI)程序的認識不斷提高,是推動市場發展的關鍵因素之一。此外,一些國家的管理當局正在資助研究和開發(R&D)活動,以鼓勵引進先進的癌症解決方案。這些當局也對醫療行業的發展進行了大量投資,這為行業參與者提供了有利可圖的成長機會。除此之外,主要的市場參與者正專注於產品的推出,在全球範圍內發展個性化醫療。他們也在整合液體活體組織切片的技術進步,以提供更好的程序工作流程和產出。再加上擴大採用基於血液的活體組織切片測試來進行早期腫瘤檢測,這對市場產生了積極的影響。此外,外泌體在腫瘤學臨床診斷中的使用越來越多,以提供高精確度和減少程序時間,這也催化了對液體活體組織切片的需求。數位聚合酶鏈反應(PCR)和基於下一代測序(NGS)技術的快速發展是推動市場成長的誘導因素。

本報告回答的關鍵問題:

  • 迄今為止,全球液體活體組織切片市場的表現如何,在未來幾年將如何表現?
  • COVID-19對全球液體活體組織切片市場的影響是什麼?
  • 主要的區域市場是什麼?
  • 基於產品和服務的市場細分是什麼?
  • 基於循環生物標記的市場細分是什麼?
  • 基於癌症類型的市場細分是什麼?
  • 基於終端用戶的市場細分是什麼?
  • 該行業價值鏈的各個階段是什麼?
  • 該行業的關鍵驅動因素和挑戰是什麼?
  • 全球液體活體組織切片市場的結構是什麼,誰是主要的參與者?
  • 該行業的競爭程度如何?

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球液體活體組織切片市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按產品和服務分類的市場

  • 試劑盒和試劑
    • 市場趨勢
    • 市場預測
  • 平台和儀器
    • 市場趨勢
    • 市場預測
  • 服務
    • 市場趨勢
    • 市場預測

第7章:按循環生物標記分類的市場

  • 循環腫瘤細胞
    • 市場趨勢
    • 市場預測
  • 細胞外囊泡
    • 市場趨勢
    • 市場預測
  • 循環腫瘤DNA
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章:按癌症類型分類的市場

  • 肺癌
    • 市場趨勢
    • 市場預測
  • 乳腺癌
    • 市場趨勢
    • 市場預測
  • 結直腸癌
    • 市場趨勢
    • 市場預測
  • 前列腺癌
    • 市場趨勢
    • 市場預測
  • 肝癌
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章:按終端用戶分類的市場

  • 醫院和實驗室
    • 市場趨勢
    • 市場預測
  • 學術和研究中心
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章:價值鏈分析

第十三章:波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章:價格分析

第十五章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • ANGLE plc
    • Biocept Inc.
    • Bio-Rad Laboratories Inc
    • Epigenomics AG
    • Exact Sciences Corporation
    • F.Hoffmann-La Roche AG
    • Guardant Health Inc.
    • Illumina Inc.
    • MDxHealth SA
    • Menarini Silicon Biosystems
    • QIAGEN NV
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A5125

The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.

Liquid biopsy is a non-invasive alternative to surgical biopsies enabling doctors to obtain information about a tumor through a blood sample and plan the treatment accordingly. It can reflect changes in tumor gene expression profile and offer a robust base for individualized therapy. It assists in the early diagnosis screening, tumor heterogeneity and drug resistance. Besides this, it also detects epidermal growth factor receptor (EGFR) gene mutations, which occur among patients with non-small cell lung cancer (NSCLC).

Liquid Biopsy Market Trends:

Due to sedentary lifestyles and rising tobacco consumption, there is a surge in the number of cancer patients across the globe. This, along with the growing awareness among individuals about advanced minimally invasive (MI) procedures in cancer diagnostics, represents one of the key factors driving the market. Moreover, governing authorities of several countries are financing research and development (R&D) activities to encourage the introduction of advanced cancer solutions. These authorities are also considerable investing in the development of the healthcare industry, which is offering lucrative growth opportunities to industry players. Apart from this, key market players are focusing on product launches to develop personalized medicine worldwide. They are also integrating technological advancements in liquid biopsy to offer better procedure workflow and output. This, coupled with the rising adoption of blood-based biopsy tests for early tumor detection, is positively influencing the market. Additionally, the increasing usage of exosomes for clinical diagnosis in oncology to provide high accuracy and reduced procedural time is catalyzing the demand for liquid biopsy. Growth-inducing factors projected to impel the market growth are rapid development in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) based technology.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid biopsy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, circulating biomarker, cancer type and end user.

Breakup by Product and Service:

Kits and Reagents

Platforms and Instruments

Services

Breakup by Circulating Biomarker:

Circulating Tumor Cells

Extracellular Vesicles

Circulating Tumor DNA

Others

Breakup by Cancer Type:

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Liver Cancer

Others

Breakup by End User:

Hospitals and Laboratories

Academic and Research Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global liquid biopsy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global liquid biopsy market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the circulating biomarker?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global liquid biopsy market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Liquid Biopsy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platforms and Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Circulating Biomarker

  • 7.1 Circulating Tumor Cells
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Extracellular Vesicles
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Circulating Tumor DNA
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Cancer Type

  • 8.1 Lung Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Breast Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Colorectal Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ANGLE plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Biocept Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Bio-Rad Laboratories Inc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Epigenomics AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Exact Sciences Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F.Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Guardant Health Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 MDxHealth SA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Menarini Silicon Biosystems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 QIAGEN N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Liquid Biopsy Market: Major Drivers and Challenges
  • Figure 2: Global: Liquid Biopsy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Liquid Biopsy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Liquid Biopsy Market: Breakup by Product and Service (in %), 2022
  • Figure 5: Global: Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2022
  • Figure 6: Global: Liquid Biopsy Market: Breakup by Cancer Type (in %), 2022
  • Figure 7: Global: Liquid Biopsy Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Liquid Biopsy Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Liquid Biopsy (Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Liquid Biopsy (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Liquid Biopsy (Platforms and Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Liquid Biopsy (Platforms and Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Liquid Biopsy (Circulating Tumor Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Liquid Biopsy (Circulating Tumor Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Liquid Biopsy (Extracellular Vesicles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Liquid Biopsy (Extracellular Vesicles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Liquid Biopsy (Circulating Tumor DNA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Liquid Biopsy (Circulating Tumor DNA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Liquid Biopsy (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Liquid Biopsy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Liquid Biopsy (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Liquid Biopsy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Liquid Biopsy (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Liquid Biopsy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Liquid Biopsy (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Liquid Biopsy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Liquid Biopsy (Liver Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Liquid Biopsy (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Liquid Biopsy (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Liquid Biopsy (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Liquid Biopsy (Hospitals and Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Liquid Biopsy (Hospitals and Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Liquid Biopsy (Academic and Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Liquid Biopsy (Academic and Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Liquid Biopsy Market: Breakup by Country (in %), 2022
  • Figure 89: Middle East and Africa: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Liquid Biopsy Industry: SWOT Analysis
  • Figure 91: Global: Liquid Biopsy Industry: Value Chain Analysis
  • Figure 92: Global: Liquid Biopsy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liquid Biopsy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Liquid Biopsy Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
  • Table 3: Global: Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2023-2028
  • Table 4: Global: Liquid Biopsy Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 5: Global: Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Liquid Biopsy Market: Competitive Structure
  • Table 8: Global: Liquid Biopsy Market: Key Players